In aggregate the valuations for the midcap are not too far away from long period averages while small caps are still away from their own mean. But as always there are differences across sectors. I do not see major froth building in a hurry and expect opportunities to be available on a bottom basis across both cohorts for investors looking at the next few quarters.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.
May 25, 2026